Home
Activity Overview
Activity Overview
Dana Ataya, MD, has written more than a hundred songs.Whenever she thinks of a new lyric or melody that may work for another tune, she…
Overview Join us for an exciting symposium to celebrate the 10th Anniversary of NCI funding projects in the Affordable Cancer Technologies (ACTs) program. Since the…
The PRIME initiative provides enhanced support to developers of promising medicines to optimize development plans and accelerate evaluation Pivotal trials…
An abstract is unavailable.
Lubna Naaz Chaudhary, MD, MS, discusses selecting a CDK4/6 inhibitor in hormone receptor–positive breast cancer.
David M. Swoboda, MD, and Andrew Kuykendall, MD, spoke about the current treatment strategies and potential advancements that may improve outcomes such as spleen volume…
This cross-sectional study of data from the Agency for Healthcare Research and Quality’s Healthcare Cost and Utilization Project National Inpatient Sample investigates whether housing status…
The UK MHRA approved frontline toripalimab plus chemotherapy for recurrent/metastatic NPC, as well as for advanced, recurrent, or metastatic ESCC.
Published online: September 14, 2024 Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides…
Online resource for healthcare professionals, providing information, news & support relating to AML